CONMED Corporation (CNMD)
NYSE: CNMD
· Real-Time Price · USD
46.00
0.01 (0.02%)
At close: Sep 26, 2025, 3:59 PM
46.50
1.09%
After-hours: Sep 26, 2025, 06:57 PM EDT
CONMED Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General Surgery Revenue | 201.61M | 182.97M | 206.94M | 186.16M | 192.56M | 177.36M | 190.52M | 179.91M | 176.86M | 164.29M | 135.66M | 156.47M | 157.01M | 134.81M | 156.36M | 143.08M | 147.27M | 125.51M | 135.65M | 97.3M | 114.73M | 123.26M | 122.51M | 104.94M | 99.38M | 102.69M | 93.2M | 101.54M | 91.54M | 91.59M | 82.78M | 92.51M | 85.44M | 87.57M | 75.9M | 70.89M | 66.12M | 71.11M | 66.06M | 75.42M | 69.73M | 70.75M | 63.46M | 76.83M | 69.89M | 73.18M | 66.85M |
| General Surgery Revenue Growth | +10.19% | -11.59% | +11.16% | -3.32% | +8.57% | -6.91% | +5.90% | +1.72% | +7.65% | +21.11% | -13.30% | -0.34% | +16.47% | -13.78% | +9.28% | -2.85% | +17.33% | -7.47% | +39.41% | -15.19% | -6.92% | +0.62% | +16.74% | +5.60% | -3.22% | +10.18% | -8.21% | +10.93% | -0.06% | +10.65% | -10.52% | +8.27% | -2.43% | +15.37% | +7.06% | +7.22% | -7.01% | +7.64% | -12.40% | +8.15% | -1.43% | +11.48% | -17.40% | +9.93% | -4.51% | +9.48% | n/a |
| Orthopedic Surgery Revenue | 140.73M | 138.29M | 139M | 130.54M | 139.54M | 134.91M | 136.53M | 124.67M | 140.79M | 131.18M | 115.21M | 118.62M | 120.18M | 107.52M | 117.61M | 105.75M | 107.89M | 107.17M | 102.19M | 60.48M | 99.28M | 110.33M | 115.76M | 113.44M | 102.93M | 110.13M | 108.86M | 121.01M | 98.58M | 105.56M | 103.79M | 98.03M | 86.26M | 92.74M | 93.44M | 104.17M | 89.38M | 96.8M | 98.6M | 101.69M | 92.75M | 102.36M | 105.95M | 107.75M | 95.56M | 101.85M | 105.01M |
| Orthopedic Surgery Revenue Growth | +1.77% | -0.51% | +6.48% | -6.45% | +3.43% | -1.18% | +9.51% | -11.45% | +7.33% | +13.86% | -2.87% | -1.30% | +11.78% | -8.58% | +11.22% | -1.99% | +0.68% | +4.87% | +68.95% | -39.08% | -10.01% | -4.69% | +2.05% | +10.21% | -6.54% | +1.17% | -10.04% | +22.75% | -6.61% | +1.71% | +5.88% | +13.64% | -6.99% | -0.75% | -10.30% | +16.54% | -7.66% | -1.82% | -3.04% | +9.64% | -9.39% | -3.38% | -1.67% | +12.75% | -6.18% | -3.01% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas (Excluding The United States) Revenue | 31.88M | 30.11M | 29.96M | 28.82M | 31.64M | 30.62M | 30.74M | 29.33M | 32.1M | 28.76M | 25.39M | 26.69M | 29.61M | 24.42M | 25.69M | 24.74M | 21.89M | 24.87M | 23.58M | 21.13M | 10.22M | 23.78M | 16.38M | 48.85M | 47.21M | 45.01M | 18.21M | 44.59M | 49.87M | 48.9M |
| Americas (Excluding The United States) Revenue Growth | +5.88% | +0.47% | +3.97% | -8.91% | +3.31% | -0.39% | +4.80% | -8.61% | +11.62% | +13.26% | -4.86% | -9.85% | +21.22% | -4.94% | +3.86% | +13.01% | -12.00% | +5.49% | +11.57% | +106.81% | -57.03% | +45.19% | -66.47% | +3.48% | +4.89% | +147.13% | -59.16% | -10.58% | +1.98% | n/a |
| Asia Pacific Revenue | 52.08M | 43.71M | 49.68M | 49.21M | 51.41M | 44.39M | 45.4M | 53.28M | 52.61M | 46.11M | 36.77M | 45.47M | 43.88M | 36.37M | 45.9M | 43.63M | 42.42M | 39.26M | 39.65M | 41.81M | 30.28M | 28.86M | 27.02M | 84.3M | 77.72M | 65.03M | 25.87M | 75.57M | 69.69M | 60.15M |
| Asia Pacific Revenue Growth | +19.15% | -12.02% | +0.96% | -4.27% | +15.81% | -2.24% | -14.79% | +1.29% | +14.10% | +25.41% | -19.14% | +3.62% | +20.63% | -20.77% | +5.21% | +2.85% | +8.04% | -0.97% | -5.16% | +38.07% | +4.92% | +6.81% | -67.95% | +8.47% | +19.51% | +151.42% | -65.77% | +8.44% | +15.85% | n/a |
| Emea Revenue | 67.78M | 63.68M | 63M | 55.52M | 63.69M | 60.86M | 60.52M | 51.44M | 58.28M | 56.02M | 45.89M | 47.21M | 54.53M | 50.31M | 53.78M | 44.06M | 47.26M | 44.6M | 48.01M | 40.69M | 29.86M | 42.52M | 32.1M | 77.66M | 93.72M | 92.66M | 32.05M | 69.4M | 86.77M | 82.57M |
| Emea Revenue Growth | +6.44% | +1.08% | +13.46% | -12.82% | +4.65% | +0.56% | +17.65% | -11.74% | +4.05% | +22.07% | -2.81% | -13.41% | +8.39% | -6.45% | +22.05% | -6.78% | +5.98% | -7.12% | +18.00% | +36.26% | -29.78% | +32.46% | -58.66% | -17.14% | +1.14% | +189.15% | -53.82% | -20.03% | +5.09% | n/a |
| United States Revenue | 190.61M | 183.76M | 203.3M | 183.15M | 185.37M | 176.41M | 190.38M | 170.52M | 174.67M | 164.59M | 142.82M | 155.72M | 149.18M | 131.23M | 148.6M | 136.4M | 143.59M | 123.94M | 141.59M | 134.21M | 87.42M | 118.85M | 48.3M | 256.36M | 257.87M | 234.05M | 48.68M | 215.06M | 219.31M | 212.5M |
| United States Revenue Growth | +3.73% | -9.61% | +11.00% | -1.20% | +5.08% | -7.34% | +11.65% | -2.37% | +6.12% | +15.24% | -8.28% | +4.38% | +13.68% | -11.69% | +8.94% | -5.01% | +15.85% | -12.46% | +5.50% | +53.51% | -26.44% | +146.07% | -81.16% | -0.58% | +10.18% | +380.80% | -77.36% | -1.94% | +3.20% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 136.02M | 144.85M | 132.67M | 99.73M | 121.84M | 106.1M | 127.33M | 125.3M | 129.7M | 130.08M | 120.74M | 114.6M | 115.83M | 102.88M | 107.28M | 104.74M | 104.4M | 98.34M | 99.1M | 94.38M | 84.47M | 95.87M | 102M | 98.19M | 100.73M | 99.23M | 96.46M | 84.98M | 89.6M | 84.57M | 92.41M | 80.81M | 83.83M | 94.76M | 86.72M | 79.01M | 86.73M | 85.94M | 82.67M | 72.06M | 73.58M | 74.79M |
| Selling, General, and Administrative Revenue Growth | -6.09% | +9.18% | +33.03% | -18.15% | +14.84% | -16.68% | +1.62% | -3.40% | -0.29% | +7.74% | +5.36% | -1.06% | +12.59% | -4.11% | +2.43% | +0.32% | +6.16% | -0.76% | +5.00% | +11.73% | -11.88% | -6.01% | +3.89% | -2.52% | +1.51% | +2.87% | +13.51% | -5.16% | +5.95% | -8.48% | +14.35% | -3.60% | -11.54% | +9.27% | +9.76% | -8.90% | +0.91% | +3.96% | +14.73% | -2.07% | -1.61% | n/a |
| Research and Development Revenue | 14.14M | 12.95M | 13.18M | 13.56M | 14.1M | 13.59M | 14.03M | 12.46M | 13.57M | 12.54M | 12.22M | 12.77M | 11.49M | 10.67M | 11.36M | 10.86M | 11.32M | 10.03M | 11.72M | 9.94M | 8.7M | 10.12M | 12.09M | 10.98M | 11.81M | 10.57M | 10.37M | 14.12M | 9.98M | 7.71M | 8.38M | 8.27M | 8.04M | 7.62M | 7.63M | 8.35M | 8.01M | 8.26M | 6.74M | 6.65M | 7.5M | 6.54M |
| Research and Development Revenue Growth | +9.20% | -1.74% | -2.82% | -3.83% | +3.71% | -3.09% | +12.55% | -8.16% | +8.24% | +2.61% | -4.28% | +11.09% | +7.69% | -6.06% | +4.62% | -4.06% | +12.88% | -14.42% | +17.91% | +14.21% | -14.03% | -16.32% | +10.10% | -6.95% | +11.64% | +1.97% | -26.56% | +41.43% | +29.49% | -7.96% | +1.31% | +2.85% | +5.55% | -0.21% | -8.61% | +4.30% | -3.02% | +22.50% | +1.34% | -11.32% | +14.66% | n/a |